You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Alclometasone dipropionate - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for alclometasone dipropionate and what is the scope of patent protection?

Alclometasone dipropionate is the generic ingredient in two branded drugs marketed by Fougera Pharms, Glenmark Generics, and Taro, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for alclometasone dipropionate. Three suppliers are listed for this compound.

Summary for alclometasone dipropionate

US Patents:	0
Tradenames:	2
Applicants:	3
NDAs:	8
Drug Master File Entries:	3
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	41
Clinical Trials:	1
Patent Applications:	5,216
Drug Prices:	Drug price trends for alclometasone dipropionate
What excipients (inactive ingredients) are in alclometasone dipropionate?	alclometasone dipropionate excipients list
DailyMed Link:	alclometasone dipropionate at DailyMed

See drug prices for alclometasone dipropionate

Recent Clinical Trials for alclometasone dipropionate

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GlaxoSmithKline	Phase 2

See all alclometasone dipropionate clinical trials

Pharmacology for alclometasone dipropionate

Drug Class	Corticosteroid
Mechanism of Action	Corticosteroid Hormone Receptor Agonists

US Patents and Regulatory Information for alclometasone dipropionate

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Taro	ALCLOMETASONE DIPROPIONATE	alclometasone dipropionate	OINTMENT;TOPICAL	076730-001	Jul 29, 2004	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Fougera Pharms	ACLOVATE	alclometasone dipropionate	CREAM;TOPICAL	018707-001	Dec 14, 1982		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Glenmark Generics	ALCLOMETASONE DIPROPIONATE	alclometasone dipropionate	OINTMENT;TOPICAL	079227-001	Jul 30, 2009	AB	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for alclometasone dipropionate

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Fougera Pharms	ACLOVATE	alclometasone dipropionate	CREAM;TOPICAL	018707-001	Dec 14, 1982	⤷ Try a Trial	⤷ Try a Trial
Fougera Pharms	ACLOVATE	alclometasone dipropionate	OINTMENT;TOPICAL	018702-001	Dec 14, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.